A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma

NCT06594991 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

88

Enrollment

OTHER

Sponsor class

Conditions

Advanced Melanoma

Interventions

DRUG: Fianlimab
DRUG: Cemiplimab
DRUG: Ipilimumab

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]